JPWO2021046448A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021046448A5
JPWO2021046448A5 JP2022514679A JP2022514679A JPWO2021046448A5 JP WO2021046448 A5 JPWO2021046448 A5 JP WO2021046448A5 JP 2022514679 A JP2022514679 A JP 2022514679A JP 2022514679 A JP2022514679 A JP 2022514679A JP WO2021046448 A5 JPWO2021046448 A5 JP WO2021046448A5
Authority
JP
Japan
Prior art keywords
epithelial cells
pharmaceutical composition
optionally
cells
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547080A (ja
JP2022547080A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049541 external-priority patent/WO2021046448A1/en
Publication of JP2022547080A publication Critical patent/JP2022547080A/ja
Publication of JPWO2021046448A5 publication Critical patent/JPWO2021046448A5/ja
Publication of JP2022547080A5 publication Critical patent/JP2022547080A5/ja
Priority to JP2025111395A priority Critical patent/JP2025143368A/ja
Pending legal-status Critical Current

Links

JP2022514679A 2019-09-04 2020-09-04 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法 Pending JP2022547080A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025111395A JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962895737P 2019-09-04 2019-09-04
US62/895,737 2019-09-04
US201962923770P 2019-10-21 2019-10-21
US62/923,770 2019-10-21
US201962924359P 2019-10-22 2019-10-22
US62/924,359 2019-10-22
US202062964995P 2020-01-23 2020-01-23
US62/964,995 2020-01-23
PCT/US2020/049541 WO2021046448A1 (en) 2019-09-04 2020-09-04 Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025111395A Division JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Publications (3)

Publication Number Publication Date
JP2022547080A JP2022547080A (ja) 2022-11-10
JPWO2021046448A5 true JPWO2021046448A5 (https=) 2024-04-02
JP2022547080A5 JP2022547080A5 (https=) 2024-04-02

Family

ID=74853054

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022514679A Pending JP2022547080A (ja) 2019-09-04 2020-09-04 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法
JP2025111395A Pending JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025111395A Pending JP2025143368A (ja) 2019-09-04 2025-07-01 超長鎖多価不飽和脂肪酸であるエロバノイドヒドロキシル化誘導体、および使用方法

Country Status (9)

Country Link
US (1) US20220339134A1 (https=)
EP (1) EP4025201A4 (https=)
JP (2) JP2022547080A (https=)
CN (1) CN114650814A (https=)
AU (1) AU2020343029A1 (https=)
BR (1) BR112022003985A2 (https=)
CA (1) CA3153088A1 (https=)
MX (1) MX2022002687A (https=)
WO (1) WO2021046448A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4210689A4 (en) * 2020-09-10 2024-11-13 Board of Supervisors of Louisiana State University and Agricultural and Mechanical College VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS, HYDROXYLATED ELOVANOID DERIVATIVES AND METHODS OF USE THEREOF
CN118524834A (zh) * 2021-12-03 2024-08-20 株式会社日水 氧化应激缓和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102256990B (zh) * 2008-10-03 2014-09-24 聚糖生物科学有限责任公司 阴离子寡糖轭合物
US20130190399A1 (en) * 2009-10-31 2013-07-25 Martek Biosciences Corporation Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA)
JP7025212B2 (ja) * 2015-02-09 2022-02-24 ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ 炎症性、変性及び神経変性疾患の治療のための化合物、組成物及び方法
US20170014365A1 (en) * 2015-07-14 2017-01-19 The Board Of Regents Of The University Of Oklahoma Compositions Containing Very Long Chain Saturated Fatty Acids and Methods of Use
WO2017077528A2 (en) * 2015-11-02 2017-05-11 Salzman Lovelace Investments, Ltd. Methods and pharmaceutical compositions for treatment of lung inflammation
CN110730769A (zh) * 2017-03-20 2020-01-24 路易斯安娜州立大学监测委员会,农业和机械学院 极长链多不饱和脂肪酸、类延长素(elovanoid)羟基化衍生物和使用方法
US20220226270A1 (en) * 2019-04-04 2022-07-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use

Similar Documents

Publication Publication Date Title
US8785393B2 (en) Ophthalmic pharmaceutical compositions of DP2 receptor antagonists
CN110105200A (zh) 用于治疗纤维化的经取代的芳族化合物及相关方法
RU2012131251A (ru) Композиции и способы для лечения связанных с ангиогенезом заболеваний глаз
KR102618119B1 (ko) 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물
JP2020023558A (ja) ノカルダミンの新規金属錯体および医薬組成物におけるそれらの使用
WO2011098801A1 (en) Inflammatory disease treatment
JP2023503380A (ja) ペプチド及び炎症の治療におけるそれらの使用
US11571411B2 (en) Use of a bisamide derivative of malonic acid for treating allergic and other diseases in humans and animals
JPWO2021046448A5 (https=)
US20220105082A1 (en) New formulations containing leukotriene receptor antagonists
US11179363B2 (en) Non-steroidal selective glucocorticoid receptor agonistic modulators (SEGRAMs) and uses thereof
TWI499419B (zh) 基於激肽b2受體拮抗劑及皮質類固醇之醫藥組成物,及其用途
US20190151283A1 (en) NON-STEROIDAL SELECTIVE GLUCOCORTICOID RECEPTOR AGONISTIC MODULATORS (SEGRAMs) AND USES THEREOF
KR20190060694A (ko) N-아세틸 또는 n-아실 아미노산을 포함하는 아토피 또는 가려움증 치료용 조성물
Ai et al. Effects of Xingbi gel on leukotriene E4 and immunoglobulin E production and nasal eosinophilia in a guinea pig model for allergic rhinitis
US11197851B2 (en) Methods of treatment of asthma and COPD
CN115484943B (zh) Cxcl8(白介素-8)活性抑制剂与皮质类固醇的组合及药物组合物及其用途
CN104427982B (zh) 治疗炎性和免疫障碍的组合物
KR20170050540A (ko) 메트포민을 유효성분으로 포함하는 피부질환 예방 또는 치료용 약학적 조성물
CN107405334B (zh) 伴随干燥综合征的干眼症的治疗剂
JP2023522062A (ja) 代謝異常を治療するためのベンズイミダゾール化合物
CN106572969A (zh) 用于治疗银屑病的药物组合物
JPH09309830A (ja) 有機化合物
JP2022067848A (ja) 経鼻投与用医薬組成物
HK40045655B (zh) 丙二酸的双酰胺衍生物用於在人和动物中治疗变应性疾病和其他疾病的用途